Brainsway Ltd. Sponsored ADR

BWAY Healthcare Medical Devices

Brainsway Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $52.2 million, up 27.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.4%, EPS grew 40.0% and free cash flow fell 51.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

11.41 0.41 −3.47%
Market cap
$475.8M
P/E
24.8×
Fwd P/E
0.0×
Dividend yield
—
F-score
6/9
Altman Z
2.82
Beneish M
−2.45
Dividend safety
n/a

Brainsway Ltd. Sponsored ADR (BWAY) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Brainsway Ltd. Sponsored ADR (BWAY) trades at a P/E ratio of 24.8×. Over the past ten years it has ranged from 0.0× (June 2024) to 229× (September 2024); the current reading is higher than 69% of that period. That is above the Medical Devices industry median of 23.2× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 26.4× (52.43%)
FY2024 55.5× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 33.7× 6.56%
Mar 2026 31.6× 19.78%
Dec 2025 26.4× (15.92%)
Sep 2025 31.4× 5.04%
31 more quarters

Against its own ten years

Low 0.0× High 229×
Ten-year median 0.0×
Current reading's percentile 69

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on BWAY